Vascular Biogenics Ltd. VBLT
0.16 0.00 (+0.00%)
At closeOct 16, 2023, 4:00 PM EDT
0.1526 Day range 0.1925
52-week range unavailable
Analyst view
Consensus: hold
Hold
Price target (mean) —
Ratings (0m) 4 4 buy · 0 hold · 0 sell
- Strong buy0
- Buy4
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 4
- 1 month ago 2
- 2 months ago 2
- 3 months ago 4
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -0.12 | 0.0% | 0 | 0.0% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -0.13 | 0.0% | 0 | 0.0% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 0 | 0.0% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 1.92M | 0.0% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 20, 2022 | Chardan Capital | Downgrade | Buy | Neutral |
| Jul 19, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Apr 27, 2022 | Chardan Capital | Initiated | — | Buy |
| Jun 2, 2021 | Roth Capital | Maintained | — | Buy |
| Jan 27, 2021 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 16, 2020 | Oppenheimer | Maintained | — | Outperform |
| Jun 26, 2019 | Oppenheimer | Initiated | — | Outperform |
| Oct 14, 2018 | HC Wainwright & Co. | Upgrade | Neutral | Buy |
| Mar 8, 2018 | Chardan Capital | Downgrade | Buy | Neutral |
| Mar 7, 2018 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Mar 27, 2017 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jun 27, 2016 | HC Wainwright & Co. | Initiated | — | Buy |
| Mar 8, 2016 | JMP Securities | Maintained | — | Market Outperform |
| Nov 8, 2015 | Piper Sandler | Initiated | — | Overweight |
| Sep 20, 2015 | Chardan Capital | Initiated | — | Buy |
| May 21, 2015 | Roth Capital | Initiated | — | Buy |
| Feb 16, 2015 | Oppenheimer | Downgrade | Outperform | Perform |
| Feb 16, 2015 | JMP Securities | Downgrade | Market Outperform | Market Perform |
| Jan 21, 2015 | Deutsche Bank | Maintained | — | Buy |